Cat.#: ACPP-1204
| Despition | P2Y1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg | inquiry |
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1701 | Human SERPINA3 Protein (AC1701) | 5 µg | inquiry |
| ACPP-1016 | Synthetic Nanodisc Human GnRHR Protein (AC1016) | 10 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1403 | Human Insulin (Active) Protein (AC1403) | 1 mg | inquiry |
| ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
| ACPP-1178 | Recombinant Human CXCR4 Protein (Fc Tag) (AC1178) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.